A study to investigate the safety and efficacy of ZS in patients with hyperkalemia.

Trial Identifier: D9480C00001
Sponsor: AstraZeneca
NCTID:: NCT03528681
Start Date: May 2021
Primary Completion Date: September 2022
Study Completion Date: September 2022
Condition: Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Chinese Translation

Trial Locations

Country Location
CN Beijing, CN, 102206
CN Beijing, CN, 100029
CN Beijing, CN, 100144
CN Bengbu, CN, 233060
CN Changsha, CN, 430033
CN Chengdu, CN, 610041
CN Chengdu, CN, 610072
CN Dongguan, CN, 523009
CN fuzhou, CN, 350005
CN guangzhou, CN, 510080
CN Guangzhou, CN, 510120
CN Guangzhou, CN, 510080
CN Guiyang, CN, 550004
CN Hangzhou, CN, 310003
CN Hefei, CN, 230022
CN Jingzhou, CN, 434020
CN Kunming, CN, 650021
CN Lanzhou, CN, 730030
CN Nanchang, CN, 330006
CN Shanghai, CN, 200127
CN Shanghai, CN, 200090
CN Shanghai, CN, 200025
CN Suzhou, CN, 215006
CN taiyuan, CN, 030001
CN Taiyuan, CN, 030012
CN Tianjin, CN, 300121
CN Tianjin, CN, 300211
CN Wuhan, CN, 430030
CN Xian, CN, 710061
CN Xining, CN, 810001
CN Yangzhou, CN, 225001
CN Yichang, CN, 443003
CN Yinchuan, CN, 750004
CN Zhanjiang, CN, 524001
CN Zhuzhou, CN, 412007
IN Ahmedabad, IN, 380006
IN Ahmedabad, IN, 380015
IN Bengaluru, IN, 560004
IN Nagpur, IN, 440012
IN New Delhi, IN, 110002
IN New Delhi, IN, 110017
IN Vijayawada, IN, 522002